These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6452055)

  • 1. Altered cellular immune functions in patients with Down's syndrome.
    Spina CA; Smith D; Korn E; Fahey JL; Grossman HJ
    Am J Dis Child; 1981 Mar; 135(3):251-5. PubMed ID: 6452055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological features of Down's syndrome: a review.
    Nespoli L; Burgio GR; Ugazio AG; Maccario R
    J Intellect Disabil Res; 1993 Dec; 37 ( Pt 6)():543-51. PubMed ID: 8124000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell response to anti-CD3 antibody in Down's syndrome.
    Bertotto A; Arcangeli C; Crupi S; Marinelli I; Gerli R; Vaccaro R
    Arch Dis Child; 1987 Nov; 62(11):1148-51. PubMed ID: 2961309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte surface markers and serum immunoglobulins in persons with Down's syndrome.
    Hann HW; Deacon JC; London WT
    Am J Ment Defic; 1979 Nov; 84(3):245-51. PubMed ID: 160754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derangements of immunoglobulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down's syndrome at different ages.
    Burgio GR; Ugazio AG; Nespoli L; Marcioni AF; Bottelli AM; Pasquali F
    Eur J Immunol; 1975 Sep; 5(9):600-3. PubMed ID: 11993318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the immune system in Down's syndrome patients].
    Rascón Trincado MV; Lorente Toledano F; Muriel Ramos MM; Romo Cortina A; Salazar Villalobos V
    Allergol Immunopathol (Madr); 1984; 12(1):45-52. PubMed ID: 6233858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatally diagnosable differences in the cellular immunity of fetuses with Down's and Edwards' syndrome.
    Zizka Z; Calda P; Fait T; Haakova L; Kvasnicka J; Viskova H
    Fetal Diagn Ther; 2006; 21(6):510-4. PubMed ID: 16969005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T lymphocytes in patients with Down's syndrome.
    Wisniewski K; Cobill JM; Wilcox CB; Caspary EA; Williams DG; Wisniewski HM
    Biol Psychiatry; 1979 Jun; 14(3):463-71. PubMed ID: 157786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological and purine enzyme studies on hyperuricaemic and normouricaemic patients with Down's syndrome.
    Watts RW; Perera YS; Allsop J; Newton C; Platts-Mills TA; Webster AD
    Clin Exp Immunol; 1979 Jun; 36(3):355-63. PubMed ID: 158448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoregulatory CD4+ CD45R+ suppressor/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome.
    Raziuddin S; Elawad ME
    Clin Exp Immunol; 1990 Jan; 79(1):67-71. PubMed ID: 1967994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of lymphocyte beta-adrenergic receptor in Down's syndrome: a biological marker of a neuroimmune deficit.
    Morale MC; Batticane N; Cioni M; Marchetti B
    J Neuroimmunol; 1992 Jun; 38(3):185-98. PubMed ID: 1318320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T and B lymphocytes in patients with Down's syndrome.
    Reiser K; Whitcomb C; Robinson K; MacKenzie MR
    Am J Ment Defic; 1976 May; 80(6):613-9. PubMed ID: 134638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered T-cell subsets and defective T-cell function in young children with Down syndrome (trisomy-21).
    Noble RL; Warren RP
    Immunol Invest; 1987 Aug; 16(5):371-82. PubMed ID: 2961683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Humoral and cellular immunity in children with Down's syndrome].
    Lukas A; Cesarz E; Lukas W; Sychłowy A; Sliwa F
    Pediatr Pol; 1980 Jan; 55(1):33-40. PubMed ID: 6445054
    [No Abstract]   [Full Text] [Related]  

  • 15. Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down's syndrome.
    Park E; Alberti J; Mehta P; Dalton A; Sersen E; Schuller-Levis G
    Clin Immunol; 2000 Apr; 95(1 Pt 1):62-9. PubMed ID: 10794433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Down syndrome: immunological study in adults (author's transl)].
    Argentiero V; Tavolato B; Bertolissi M; Gentile B; Piazza L
    Riv Patol Nerv Ment; 1979 Jun; 99(5):267-74. PubMed ID: 159484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody defined T cell subsets and autologous mixed lymphocyte reaction in Down's syndrome.
    Gupta S; Fikrig SM; Mariano E; Quazi Q
    Clin Exp Immunol; 1983 Jul; 53(1):25-30. PubMed ID: 6223734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte surface phenotypes in Down's syndrome.
    Bertotto A; Lungarotti MS; Gentili F; Vaccaro R
    Int J Tissue React; 1984; 6(3):219-21. PubMed ID: 6237071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets.
    Karttunen R; Nurmi T; Ilonen J; Surcel HM
    Clin Exp Immunol; 1984 Feb; 55(2):257-63. PubMed ID: 6230181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell activation by anti-CD3 antibodies: function of Fc receptors on B cell blasts, but not resting B cells, and CD18 on the responding T cells.
    Austyn JM; Smith KG; Morris PJ
    Eur J Immunol; 1987 Sep; 17(9):1329-35. PubMed ID: 3498637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.